Pinned
🫀How should we diagnose & manage #HCM?
This #EJHF expert consensus statement addresses the gray zones clinicians face in daily practice including:
📍Cardiac myosin inhibitors (#mavacamten, #aficamten) are now central to oHCM care
📍 SCD risk uses a hybrid model: ESC 5-year
